Navigation Links
ERT Reports Second Quarter 2009 Results
Date:7/30/2009

2009.
  • Cash and cash equivalents totaled $68.7 million at June 30, 2009 compared to $66.4 million at December 31, 2008.
  • ERT purchased 741,267 shares of its common stock at an average price of $5.43 under its approved stock repurchase program in the second quarter of 2009 at a total cost of $4.0 million.
  • Backlog was $153.7 million as of June 30, 2009 compared to $157.0 million as of March 31, 2009. The June 30, 2009 backlog excludes the backlog attributable to the EDC operations. The annualized cancellation rate was 16.1 % in the second quarter of 2009 compared to 18.1% a year ago and 22.4% in the first quarter of 2009.
  • Financial highlights for the first six months of 2009:

    • For the six months ended June 30, 2009, the Company reported net revenues of $48.0 million compared to $69.1 million for the six months ended June 30, 2008.
    • Gross margin percentage for the six months ended June 30, 2009 was 51.4% compared to 54.8% for the six months ended June 30, 2008.
    • Operating income margin for the six months ended June 30, 2009 was 17.1% compared to 27.8% for the six months ended June 30, 2008.
    • Net income was $4.6 million, or $0.09 per diluted share for the six months ended June 30, 2009 compared to net income of $12.4 million, or $0.24 per diluted share, for the six months ended June 30, 2008.
    • The results include the EDC operations, which were sold on June 23, 2009. EDC licenses and services revenue was $2.5 million and $2.8 million in the first six months of 2009 and 2008, respectively. The Company reported a $0.5 million gain on the sale of the EDC operations, which is included in general and administrative expenses.
    • New bookings for the six months ended June 30, 2009 were $66.9 million compared to $99.1 million in the six months ended June 30, 2008.
    • For the six months ended June 3
      '/>"/>

    SOURCE ERT
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related biology technology :

    1. Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
    2. Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
    3. Caliper Life Sciences Reports Second Quarter 2009 Results
    4. Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
    5. Sangamo BioSciences Reports Second Quarter 2009 Financial Results
    6. Neurocrine Biosciences Reports Second Quarter 2009 Results
    7. Sunesis Reports Financial Results for the Second Quarter 2009
    8. Cynosure Reports Second Quarter 2009 Financial Results
    9. NeoGenomics Reports Second Quarter 2009 Results
    10. Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008s $2.65.
    11. Neogen Reports 16% Increase in Revenues
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/1/2015)... , July 1, 2015   Decision ... frequently cited advantages of Otezla are its oral ... profile, as reported by surveyed rheumatologists. Otezla was ... for the treatment of active psoriatic arthritis in ... current standard of care includes conventional oral treatments ...
    (Date:7/1/2015)... CHANDLER, Ariz. , July 1, 2015 ... announced it has earned three Gold, three Silver, and ... Business Awards gala held in Chicago ... recognized as the premier business awards program in the ... and recognizes our company,s strength in developing leaders, cultivating ...
    (Date:7/1/2015)... July 1, 2015  UCB, a multinational biopharmaceutical ... global leader in designing, transforming, and running intelligent ... in recognition of their close collaboration in driving ... global business services (GBS) finance organization. ... clients that work together effectively to embrace the ...
    (Date:6/30/2015)... , June 30, 2015  NASA astronaut Kjell Lindgren ... month on his first mission to the International Space ... 8 to 9 a.m. EDT Tuesday, July 7. ... Star City, Russia . The interviews will ... Television highlighting his mission training. To schedule an ...
    Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2
    ... Ill. University of Illinois engineers have developed ... that could shrink integrated circuits and expand microelectronics. ... multiple transistors and electronic components together to perform ... boards traditionally are made from pre-fabricated metal wires ...
    ... ,, NEW YORK , July 15 Senesco Technologies (NYSE Amex: SNT ) announces the following ... What:  LHA Life Sciences & Med Tech Day 2010 Presentation , , ... Eastern , , , ... How:  Live over the Internet -- Simply log on to the web at the ...
    ... , QUEBEC CITY , July 14 ... TSX: AEZ) (the "Company"), a late-stage drug development ... announced that its partner, Keryx Biopharmaceuticals, Inc. ("Keryx") ... the U.S. Food and Drug Administration ("FDA") for ...
    Cached Biology Technology:Small wires make big connections for microelectronics 2Small wires make big connections for microelectronics 3Webcast Alert: Senesco Technologies (SNT) Announces the LHA Life Sciences & Med Tech Day 2010 Presentation 2Aeterna Zentaris Announces Perifosine Has Received Orphan-Drug Designation for the Treatment of Neuroblastoma 2Aeterna Zentaris Announces Perifosine Has Received Orphan-Drug Designation for the Treatment of Neuroblastoma 3Aeterna Zentaris Announces Perifosine Has Received Orphan-Drug Designation for the Treatment of Neuroblastoma 4
    (Date:6/24/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hhwlfj/huawei_ascend ... "Huawei Ascend Mate 7 Fingerprint Sensor - Reverse ... Huawei,s technological choice for the fingerprint sensor ... and Samsung,s one. The Ascend Mate 7 presents ... a main actor in capacitive sensing human interface ...
    (Date:6/23/2015)... PALM BEACH GARDENS, Fla. , June ... of multi-factor identity management and authentication solutions, today ... Altus strong, multi-factor authentication solution.  The ... ease of use of the DigitalPersona Altus ... and biometric reader compatibility. In ...
    (Date:6/17/2015)... SAN JOSE, Calif. , June 17, 2015 ... leader in human interface solutions, today announced that ... has adopted the Synaptics ® ClearPad ® ... family of display driver integrated circuits (DDICs) for ... Note Pro. By leveraging ClearPad for full in-cell ...
    Breaking Biology News(10 mins):Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
    ... network known to date in the plant kingdom has ... the Danforth Plant Science Center. The results of ... elaborate heterotirmeric G-protein family from soybean expands the diversity ... G-proteins are signaling proteins that direct a plant,s ...
    ... of Medicine have found that exposure during pregnancy to ... cognitive development. The findings are published online in ... 2002, the Mount Sinai Children,s Environmental Health Study enrolled ... their third trimester of pregnancy. The research team collected ...
    ... (Boston) A pulse oximetry training video produced ... for the department of anesthesiology at Boston Medical Center ... of Medicine (BUSM), and his colleagues is featured in ... The training video, which is the fifth ...
    Cached Biology News:Prenatal exposure to certain pesticides may negatively impact cognitive development in children 2Pulse oximetry training video by BMC anesthesiologist published in NEJM 2
    ... for the synthesis of 5' capped RNA ... of cap analog for a large portion ... transcription reaction results in the incorporation of ... of the transcripts. Capped mRNAs are generally ...
    ... HT is designed for extended ... HT is ideal for applications ... primer extension assays. iEMS Incubator/Shaker ... one-cabinet model, allowing the capacity ...
    ... structure called a ?cap? is present ... eukaryotic mRNAs and many viral RNAs. ... portion of the GTP present in ... in the synthesis of transcripts with ...
    Improve inventory management with stainless steel red cell canisters; ensure product safety with CO2 or LN2 backup systems. A complete solution for your blood banking needs....
    Biology Products: